Evaluating your likely current (and near future) state of health means taking into account the risk factors — such as aspirin use — that affect you. Our medical diagnosis tool, The Analyst™, identifies major risk factors by asking the right questions.
How often do you use aspirin?
Possible responses:
→ Don't know→ Never / less that once a year → Occasionally / only when I need it → Regularly - several times a month → Often - daily or almost daily |
Aspirin thins the blood and can increase bleeding. A study at the University of Oxford reported in June, 2017 that taking aspirin regularly is far more dangerous that previously thought, especially for those aged 75 or older, because of very high increased risk of dying from excess bleeding.
The recommendation is that, aside from those who have already suffered heart attacks or stroke, regular aspirin users should cease doing so gradually and under a doctor's supervision in order to prevent heart attacks. Those over 75 who continue taking aspirin should be prescribed a proton pump inhibitor (PPI), which reduces bleeding risk by up to 90%.
Inflammation may be caused by aspirin and nonsteroidal anti-inflammatory medications (NSAIDs), but the bacterium H. pylori is generally responsible.
Aspirin may damage the lining of the stomach, but it is believed that the bacterium H. pylori is usually the cause.
A study published in October 2011 and involving 4,000 elderly participants across Europe found that those who took aspirin every day were twice as likely to be diagnosed with late stage age-related macular degeneration (AMD) as those who did not.
NOTE: For those suffering from heart disease, the benefits of taking aspirin outweigh the risks posed to their vision.
During another major study at the Netherlands Institute for Neuroscience and Academic Medical Centre, researchers followed 839 people and found that among those who took aspirin each day, around 4% had an advanced form of the disease called neovascular or 'wet' AMD, which leads to the most profound blindness. In comparison, just 2% who took aspirin less frequently had the same disease.
A more conclusive Australian study was published January 2013 in the Journal of the American Medical Association (JAMA) and followed 2,400 subjects for 15 years. It found that 3.7% of the 'occasional' users of aspirin and 9.4% of the 'regular' users developed wet AMD.
Aspirin can cause tinnitus at high doses.
People who regularly take aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) have a reduced risk of developing Alzheimer's Disease.
Several studies have noted a reduction in the risk of esophageal, gastric and biliary cancers among regular aspirin users.
Aspirin may slightly reduce risk of estrogen receptor positive forms of breast cancer.
October, 2017: A study of the link between aspirin and cancer in 600,000 participants at the Chinese University of Hong Kong was presented at the 25th UEG (United European Gastroenterology) Week in Barcelona. It demonstrated that long-term use of aspirin can reduce the risk of developing many major cancers, particularly within the digestive tract.
In 2016, a study at Cardiff University found that taking aspirin daily increased survival rates for bowel, breast and prostate cancers by 20%.
Several previous studies have also demonstrated reduced mortality from various cancers among regular aspirin users. A 2012 study showed a large reduction in death from esophageal, stomach and colon cancers among daily aspirin users, and a 12% reduction for other types of cancer. [JNCI J Natl Cancer Inst (2012) 104 (16): pp1208-1217]
A study published on November 28th, 2012 in the Journal of the National Cancer Institute showed that those who used aspirin saw a 45% reduction in the risk of death from chronic liver disease. The study followed 300,000 people aged between 51 and 70 for between 10 and 12 years. Those who took other types of NSAIDs had a 26% lower chance of dying from chronic liver disease, but had no corresponding reduction in the risk of liver cancer.
October, 2017: A major Chinese study involving 600,000 subjects reported that daily aspirin use results in a 34% reduced risk of developing colorectal cancer.
Previous studies also showed that aspirin has been found to reduce the risk of colorectal cancer by up to 60%, with researchers finding that 600mg of aspirin per day for 25 months substantially reduces cancer incidence after 5 years in carriers of hereditary colorectal cancer.
A November 2012 study published in the New England Journal of Medicine showed a 34% reduction in the risk of death associated with heart attack among patients who used aspirin daily.
October, 2017: A major Chinese study involving 600,000 subjects reported that daily aspirin use results in a 47% reduced risk of developing esophageal cancer.
Several previous studies had also noted a reduction in the risk of esophageal, gastric and biliary cancers among regular aspirin users. A 2012 study showed that those who used aspirin daily had a 40% lower risk of death from esophageal cancer. [JNCI J Natl Cancer Inst (2012) 104 (16): pp1208-1217]
October, 2017: A major Chinese study involving 600,000 subjects reported that daily aspirin use results in a 24% reduced risk of developing leukemia.
October, 2017: A major Chinese study involving 600,000 subjects reported that daily aspirin use results in a 47% reduced risk of developing liver cancer.
Another study, published on November 28th, 2012 in the Journal of the National Cancer Institute, showed that those who used aspirin to treat pain saw a 41% reduction in their risk of developing liver cancer. However, the incidence of liver cancer in the general population is already very low, so the risks from aspirin far outweigh the potential benefits in those who are not at increased risk of liver cancer or liver disease.
October, 2017: A major Chinese study involving 600,000 subjects reported that daily aspirin use results in a 35% reduced risk of developing lung cancer.
October, 2017: A major Chinese study involving 600,000 subjects reported that daily aspirin use results in a 37% reduced risk of developing pancreatic cancer.
October, 2017: A major Chinese study involving 600,000 subjects reported that daily aspirin use results in a 14% reduced risk of developing prostate cancer.
October, 2017: A major Chinese study involving 600,000 subjects reported that daily aspirin use results in a 34% reduced risk of developing colorectal cancer.
October, 2017: A major Chinese study involving 600,000 subjects reported that daily aspirin use results in a 38% reduced risk of developing gastric cancer.
Several previous studies noted a reduction in the risk of esophageal, gastric and biliary cancers among regular aspirin users. A 2012 study showed that those who used aspirin daily had a 40% lower risk of death from stomach cancer. [JNCI J Natl Cancer Inst (2012) 104 (16): pp1208-17]